Santo Holding logo

Santo Holding

Europe, Zurich, Switzerland, Zürich

Description

Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.

Investor Profile

Santo Holding has made 7 investments, with 0 in the past 12 months and 43% as lead.

Stage Focus

  • Series Unknown (43%)
  • Series B (14%)
  • Series C (14%)
  • Series D (14%)
  • Post Ipo Equity (14%)

Country Focus

  • Germany (86%)
  • Austria (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Cleantech
  • Energy
  • Energy Efficiency
  • Environmental Engineering
  • Greentech
  • Manufacturing
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Santo Holding frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 1
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 2
Arax Capital Partners
Europe, Wien, Austria, Vienna
Co-Investments: 1
Co-Investments: 1
FB
Europe, Bayern, Germany, Gräfelfing
Co-Investments: 2
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 2
M
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1
MIG Capital
Europe, Bayern, Germany, München
Co-Investments: 6

What are some of recent deals done by Santo Holding?

Efficient Energy

Feldkirchen, Bayern, Germany

First mover in designing and selling clean cooling systems with natural refrigerant water.

CleanTechEnergyEnergy EfficiencyEnvironmental EngineeringGreenTechManufacturing
Series UnknownMar 13, 2019
Amount Raised: $8,272,723
Efficient Energy

Feldkirchen, Bayern, Germany

First mover in designing and selling clean cooling systems with natural refrigerant water.

CleanTechEnergyEnergy EfficiencyEnvironmental EngineeringGreenTechManufacturing
Series UnknownJun 28, 2018
Amount Raised: $7,702,448
AFFiRiS

Gerasdorf Bei Wien, Niederosterreich, Austria

AFFiRiS develops tailor-made peptide vaccines for alzheimer's, parkinson's, atheroclerosis, hypertension and several other conditions.

BiotechnologyMedicalPharmaceutical
Series UnknownJun 28, 2016
Amount Raised: $10,000,000
4SC

Planegg, Bayern, Germany

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquityJul 8, 2015
Amount Raised: $32,112,860
SuppreMol

Martinsried, Bayern, Germany

SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.

BiotechnologyHealth CareMedical Device
Series DMay 21, 2013
Amount Raised: $12,252,610
SuppreMol

Martinsried, Bayern, Germany

SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.

BiotechnologyHealth CareMedical Device
Series CDec 17, 2010
Amount Raised: $20,439,084
SuppreMol

Martinsried, Bayern, Germany

SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.

BiotechnologyHealth CareMedical Device
Series BJul 15, 2008
Amount Raised: $24,979,595